PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
123,123-02,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",22,Female,White,No,No,,,No,,No,3
123,123-03,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",29,Female,White,No,No,,,No,,No,3
123,123-04,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",24,Female,White,No,No,,,No,,No,3
123,123-05,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",38,Female,White,No,Yes,"Other, specify",New information regarding participants past medical history came to light and includes exclusionary criteria,No,,No,1
123,123-06,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",22,Male,White,No,No,,,No,,No,3
123,123-07,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",27,Female,White,No,No,,,No,,No,3
123,123-10,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",36,Female,White,No,No,,,No,,No,3
123,123-11,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",29,Male,White,No,No,,,No,,No,3
123,123-12,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",42,Male,White,No,No,,,No,,No,3
123,123-13,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",48,Male,Other,No,No,,,No,,No,3
123,123-14,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",31,Female,White,No,No,,,No,,No,3
123,123-15,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",22,Female,Black/African American,No,No,,,No,,No,3
123,123-17,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",34,Male,White,No,No,,,No,,No,3
123,123-23,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",30,Male,White,No,No,,,Yes,Unable to contact participant,No,3
123,123-26,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",38,Female,White,No,No,,,No,,No,3
123,123-29,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",24,Female,White,No,No,,,Yes,Unable to contact participant,No,3
123,123-33,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",22,Male,White,No,No,,,No,,No,3
123,123-34,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",46,Female,White,No,No,,,No,,No,3
123,123-35,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",30,Male,White,No,No,,,No,,No,3
123,123-37,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",32,Female,White,No,Yes,Adverse event,,No,,No,1
123,123-38,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",30,Female,White,No,Yes,Adverse event,,No,,No,2
123,123-42,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",20,Male,White,Yes,No,,,No,,No,3
123,123-43,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",27,Male,White,No,No,,,No,,No,3
123,123-47,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",19,Male,White,No,No,,,No,,No,3
123,123-48,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",28,Male,Black/African American,Yes,No,,,No,,No,3
123,123-52,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",28,Male,White,No,No,,,No,,No,3
123,123-56,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",28,Female,White,No,No,,,No,,No,3
123,123-58,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",27,Male,White,No,No,,,No,,No,3
123,123-59,T1,"100 mcg Stable CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",27,Female,White,No,Yes,Participant refused further participation,,Yes,Participant refused further participation,No,1
123,123-60,T2,"100 mcg Transient CH505TF gp120 + 10 mcg GLA-SE mo(0,2,6)",22,Female,White,No,Yes,Unable to contact participant,,Yes,Unable to contact participant,No,1